
The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability.
Dr. Rozaleen Dash are postdoctoral fellows at Centre of Excellence, Biopharmaceutical Technology, Indian Institute of Technology New Delhi.
The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability.
Published: November 1st 2021 | Updated: